Youlife Group Inc. (“Youlife” or the “Company”) (NASDAQ: YOUL), a leading blue-collar lifetime service provider in China, today announced that it has entered into a joint venture agreement with Sealand Maritime Service Co., Ltd. (“Sealand”), a leading cruise crew recruitment and dispatch company in China. The two parties have jointly established Xiamen Youlife Sealand International […]

Scienjoy Holding Corporation (“Scienjoy”, the “Company”, or “we”) (NASDAQ: SJ), an interactive entertainment leader in the Chinese market, today announced that on January 7, 2026, it received notification from The Nasdaq Stock Market LLC (“Nasdaq”) that Nasdaq approved the Company's request for an additional 180-calendar day extension (the “Extension”) to regain compliance with the minimum

(NASDAQ:RPRX), NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2026 of $0.235 per Class A ordinary share, reflecting a 6.8% increase in the company's quarterly dividend over the previous quarter's dividend. The dividend will

(Other OTC:LBSR),(OTC US:LBSR), TUCSON, AZ, Jan. 09, 2026 (GLOBE NEWSWIRE) — Liberty Star Minerals | Liberty Star Uranium & Minerals Corp. (OTCQB: LBSR) a U.S. exploration company focused on strategic and commercially important critical minerals based in southeast Arizona, today published a chairman's letter highlighting 2025 achievements and ongoing expectations. Dear Shareholders, As we close

(NASDAQ:NNE), Dismissal of Federal Securities Class Action Lawsuit Follows Dismissal of Related Shareholder Derivative Lawsuit New York, NY, Jan. 09, 2026 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor (MMR) and technology company focused on developing clean energy solutions, announced today that

(NYSE:IDT), December same-store sales increased 4.5% year-over-year The average price paid for the top 500 items in December increased 2.3% year-over-year NEWARK, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) — NRSInsights, a provider of sales data and analytics drawn from retail transactions processed through the National Retail Solutions (NRS) point-of-sale (POS) platform, today announced comparative retail

(NASDAQ:CLNN), Oversubscribed registered direct offering priced above market to new, existing and insider investors, including Boxer Capital Management, Coastlands Capital, and Vivo Capital Initial financing tranche of over $6 million, which we expect will provide cash runway into the third quarter of 2026 enabling funding through potential NDA acceptance decision by the FDA, with two

(NASDAQ:LXRX), -White Paper based on October 2025 Roundtable of diverse stakeholders focused on accelerating innovation and expanding access to novel non-opioid therapies- -Need for swift action by policymakers to support millions of Americans suffering from chronic pain- THE WOODLANDS, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) — In October 2025, Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) convened

(NasdaqGM:CRMD), BERKELEY HEIGHTS, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) — CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that Joseph Todisco, Chairman and CEO of CorMedix Therapeutics, will present a corporate overview at the 44th annual J.P. Morgan Healthcare Conference. The presentation

(NASDAQ:TNYA), Aims to Build on Positive 2025 Interim TN-201 Results in First Half of 2026 with Longer-Term Follow-Up Data for Cohorts 1 and 2 from MyPEAK(TM)-1 Trial of Adults with MYBPC3-Associated HCM Expects to Report One-Year Cohort 1 Data and Early Cohort 2 Data from RIDGE(TM)-1 Study of TN-401 for PKP2-Associated ARVC in First Half